Liu Tian
Clinical trials sponsored by Liu Tian, explained in plain language.
-
New hope for rare gut disease? drug shows promise in small study
Disease control CompletedThis study tested the drug ustekinumab in 8 adults with a rare and severe form of intestinal Behçet's syndrome that also involves a blood disorder called myelodysplastic syndrome. The goal was to see if the drug could improve gut symptoms and control disease activity over 24 week…
Phase: PHASE2 • Sponsor: Liu Tian • Aim: Disease control
Last updated May 26, 2026 12:01 UTC
-
New hope for rare blood vessel disease: drug shows promise in small trial
Disease control CompletedThis study tested the drug upadacitinib in 12 people with Takayasu arteritis, a rare disease where the body's immune system attacks large blood vessels. The goal was to see if the drug could help control the disease in patients who did not get better with standard treatments. The…
Sponsor: Liu Tian • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New hope for tough Behcet's: drug shows promise in small trial
Disease control CompletedThis study tested the drug upadacitinib in 27 adults with Behcet's syndrome that did not improve with standard treatments. The goal was to see if the drug could reduce symptoms and prevent new disease activity. Results showed that many patients experienced improvement, but the dr…
Phase: PHASE2 • Sponsor: Liu Tian • Aim: Disease control
Last updated May 18, 2026 12:02 UTC